Browse Studies — Arctuva

Pediatric Cardiomyopathy Mutation Analysis

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of…

CardiomyopathiesDilated CardiomyopathyHypertrophic Cardiomyopathy+3 more

Estimated

~$10 – $750

Indiana UniversityNCT02432092

Identification of Novel Genetic Variants and Biomarkers of Disease Progression in Arrhythmogenic Cardiomyopathy

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sud…

Arrhythmogenic Right Ventricular CardiomyopathyCardiomyopathiesHeart Diseases+14 more

Estimated

~$10 – $750

Mayo ClinicNCT03049254

Phase 1

First-in-Human, Open-Label, Safety, Tolerability, Dose-Finding, Pharmacodynamic and Cardiac Transgene Expression Study of TN-401, a Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, in Adults With PKP2 Mutation-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

This first-in-human study is designed to evaluate the safety, and preliminary efficacy (PD) of TN-401 gene therapy in adult patients with symptomatic PKP2 muta…

Arrhythmogenic Right Ventricular Cardiomyopathy

Estimated

~$10 – $8,750

Tenaya TherapeuticsNCT06228924

Seroprevalence Study of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV…

Arrhythmogenic Right Ventricular Cardiomyopathy

Estimated

~$10 – $1,050

Tenaya TherapeuticsNCT06311708